Cargando…

Botulinum Toxin Type A for Glabellar Frown Lines: What Impact of Higher Doses on Outcomes?

Botulinum toxin serotype-A (BoNT-A) preparations are widely used to improve the appearance of wrinkles. While effective and well tolerated, patients require retreatment over time to re-establish the effects. There is growing interest from patients as to whether higher doses can prolong response with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaufman-Janette, Joely, Cox, Sue Ellen, Dayan, Steven, Joseph, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310242/ https://www.ncbi.nlm.nih.gov/pubmed/34357966 http://dx.doi.org/10.3390/toxins13070494

Ejemplares similares

Anatomical Proposal for Botulinum Neurotoxin Injection for Glabellar Frown Lines
por: Yi, Kyu-Ho, et al.
Publicado: (2022)

Antibody-induced secondary treatment failure in a patient treated with botulinum toxin type A for glabellar frown lines
por: Stengel, Gabriele, et al.
Publicado: (2011)

Subject satisfaction and psychological well‐being with escalating abobotulinumtoxinA injection dose for the treatment of moderate to severe glabellar lines
por: Dayan, Steven, et al.
Publicado: (2022)

Anatomical Injection Guidelines for Glabellar Frown Lines Based on Ultrasonographic Evaluation
por: Kim, Soo-Bin, et al.
Publicado: (2021)

Differential characteristics of incobotulinumtoxinA and its use in the management of glabellar frown lines
por: Prager, Welf
Publicado: (2013)

Botulinum toxin type-A in the treatment of glabellar lines
por: Winter, Leslie, et al.
Publicado: (2009)

Safety, efficacy, and onset of a novel botulinum toxin type A (Nabota) for the treatment of glabellar frown lines: a single-arm, prospective, phase 4 clinical study
por: Song, Sinyoung, et al.
Publicado: (2018)

Botulinum toxin type A for the management of glabellar rhytids
por: Tremaine, Anne Marie, et al.
Publicado: (2010)

Some reasons for frowning upon the effects of botulinum toxin injections in facial muscles
por: Tilki, Hacer Erdem
Publicado: (2023)

Onset, longevity, and patient satisfaction with incobotulinumtoxinA for the treatment of glabellar frown lines: a single-arm, prospective clinical study
por: Prager, Welf, et al.
Publicado: (2013)

IncobotulinumtoxinA for Glabellar Frown Lines in Chinese Subjects: A Randomized, Double-blind, Active-Controlled Phase-3 Study
por: Wu, Yan, et al.
Publicado: (2023)

Psoriatic Lesions Following Botulinum Toxin: A Injections to the Glabellar Region
por: Ceran, Candemir, et al.
Publicado: (2015)

Keeping up appearances: Don’t frown upon the effects of botulinum toxin injections in facial muscles
por: Punga, Anna Rostedt, et al.
Publicado: (2023)

The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
por: Lorenc, Z Paul, et al.
Publicado: (2021)

Corrigendum to: The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
por: Lorenc, Z Paul, et al.
Publicado: (2021)

High-Dose Neuromodulators: A Roundtable on Making Sense of the Data in Real-World Clinical Practice
por: Fabi, Sabrina Guillen, et al.
Publicado: (2021)

Onset and duration of effect of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA in the treatment of glabellar frown lines: a randomized, double-blind study
por: Rappl, Thomas, et al.
Publicado: (2013)

Modulation of amygdala activity for emotional faces due to botulinum toxin type A injections that prevent frowning
por: Stark, Shauna, et al.
Publicado: (2023)

Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: A review of the science, the clinical data, and patient satisfaction
por: De Boulle, Koenraad, et al.
Publicado: (2010)

A Double-Blind, Randomized, Placebo-Controlled, Two-Dose Comparative Study of Botulinum Toxin Type A for Treating Glabellar Lines in Japanese Subjects
por: Harii, Kiyonori, et al.
Publicado: (2008)

Integrative Assessment for Optimizing Aesthetic Outcomes When Treating Glabellar Lines With Botulinum Toxin Type A: An Appreciation of the Role of the Frontalis
por: Bertucci, Vince, et al.
Publicado: (2022)

Neuronal effects of glabellar botulinum toxin injections using a valenced inhibition task in borderline personality disorder
por: Kruger, Tillmann H. C., et al.
Publicado: (2022)

The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
por: Kaufman-Janette, Joely, et al.
Publicado: (2021)

Tackling the ‘brown’ frown
por: Neild, G. H., et al.
Publicado: (2012)

DAXI (DaxibotulinumtoxinA) – An Innovative Approach for Frown Lines
por: Mussarat, Abdullah, et al.
Publicado: (2023)

Corrigendum to: The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
por: Kaufman-Janette, Joely, et al.
Publicado: (2021)

Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A
por: Solish, Nowell, et al.
Publicado: (2021)

Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines
por: Humphrey, Shannon, et al.
Publicado: (2023)

Optimizing Outcomes When Treating Glabellar Lines
por: Solish, Nowell, et al.
Publicado: (2023)

Central Forehead Ischemic Skin Injury following Glabellar Botulinum: A Paradigm Microshift?
por: Hynes, Stephanie D., et al.
Publicado: (2023)

Botulinum Toxin Deaths: What is the Fact?
por: Omprakash HM,, et al.
Publicado: (2008)

Safety, Pharmacodynamic Response, and Treatment Satisfaction With OnabotulinumtoxinA 40 U, 60 U, and 80 U in Subjects With Moderate to Severe Dynamic Glabellar Lines
por: Joseph, John H, et al.
Publicado: (2022)

Angiomyolipoma of the Glabellar Region
por: Kim, Hyo Joong, et al.
Publicado: (2017)

The Crest Injection Technique for Glabellar Line Correction and the Paracentral Artery
por: Tansatit, Tanvaa, et al.
Publicado: (2021)

Abstract: DWP-450, Purified Botulinum Toxin Type A, for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Subjects: Results from Two Randomized, Double-Blind, Placebo-Controlled, Single Dose Phase III Safety and Efficacy Studies
por: Lorenc, Z. Paul
Publicado: (2017)

Botulinum toxin for the treatment of hyperfunctional lines of the forehead
por: Sunil, Sathigrama Malegowda, et al.
Publicado: (2015)

Immunogenicity Associated with Botulinum Toxin Treatment
por: Bellows, Steven, et al.
Publicado: (2019)

Efficacy and safety of a new resilient hyaluronic acid dermal filler, in the correction of moderate‐to‐severe nasolabial folds: A 64‐week, prospective, multicenter, controlled, randomized, double‐blind and within‐subject study
por: Kaufman‐Janette, Joely, et al.
Publicado: (2019)

Glabellar vertical line as a reference goal for anteroposterior maxillary position
por: Carruitero, Marcos J., et al.
Publicado: (2019)

Treatment of glabellar lines with Botox (onabotulinumtoxinA): Development, insights, and impact
por: Carruthers, Jean, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ose8sbo4tuinbacl0hcbua801o